Targeted Oncology Therapy for International Healthcare Markets
Sorafenib 200 mg Tablets are a widely used targeted oncology medicine designed for advanced cancer management under specialist supervision. Known for its role in inhibiting tumor cell growth pathways, Sorafenib is an essential part of modern oncology treatment protocols across global healthcare systems.
We provide reliable export supply and wholesale distribution support for Sorafenib 200 mg Tablets to regulated and semi-regulated markets including:
United States (USA) | Germany | United Kingdom (UK) | United Arab Emirates (UAE) | Brazil | South Africa
About Sorafenib 200 mg Tablets
Sorafenib is an oral targeted therapy used in oncology treatment regimens to help control abnormal cell growth and tumor progression. It belongs to the class of multi-kinase inhibitors and is widely included in international cancer treatment protocols.
Key Product Advantages:
- Oral 200 mg tablet formulation
- Targeted cancer therapy support
- Suitable for hospital & institutional procurement
- Export-ready packaging standards
- Stable shelf-life with controlled storage conditions
Therapeutic Use (As per Oncology Prescription)
Sorafenib 200 mg Tablets are commonly prescribed in clinical oncology practice for:
- Advanced hepatocellular carcinoma (HCC)
- Renal cell carcinoma (RCC)
- Differentiated thyroid carcinoma (refractory cases)
Use strictly under supervision of qualified oncologists in accordance with local regulatory approvals.
International Supply Network
United States (USA)
High-demand oncology procurement market requiring consistent and compliant supply chains for specialty cancer medicines.
Germany & United Kingdom (Europe)
Focused on regulated pharmaceutical imports with documentation and quality compliance requirements.
United Arab Emirates (UAE)
Growing oncology treatment infrastructure with strong demand for hospital-based procurement.
Brazil
Large-scale requirement for affordable oncology generics across public healthcare systems and distributors.
South Africa
Expanding oncology care programs supported by institutional medicine imports.
Why Global Buyers Choose Us
- Consistent oncology product sourcing
- Export documentation support (GMP, COA, MSDS)
- Competitive wholesale pricing for distributors
- Bulk supply capability for tenders & institutions
- Reliable international logistics coordination
Packaging & Export Standards
- Secure blister packaging or customized bulk packs
- Export-compliant labeling formats
- Batch-wise traceability and documentation
- Temperature-conscious handling where required
Quality & Regulatory Compliance
All batches are manufactured under controlled pharmaceutical environments with:
- GMP-certified production standards
- Quality assurance testing before dispatch
- Documentation support for import registration
- Traceable batch records for regulatory audits
Order & Business Enquiry
We work with pharmaceutical importers, hospital procurement teams, oncology distributors, government tenders, and wholesale buyers worldwide.
📲 WhatsApp Order & Enquiry: +91-9405117673
📧 Email: info@cordiumpharma.com